|
|
|
|
|
|
1 |
|
|
|
Introduction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
|
Receptors/Dose-Response |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
Pharmacokinetics 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
Pharmacokinetics 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
Cholinergic Pharmacology
(Case - Anticholinesterase) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
Pharmacokinetics 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
|
Local Anesthetics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
|
Antidysrhythmics
(Case - Poison Control) |
|
|
|
Clinical Pharmacology in Massachusetts General Hospital Operating Rooms |
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
Drug Metabolism |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
|
|
|
Pharmacogenetics
(Case - Anticoagulation)
(Case - Sulfasalazine) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
|
|
Autonomic Pharmacology 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
|
|
|
Autonomic Pharmacology 2
(Case - Pheochromocytoma)
(Case - Asthma) |
|
|
|
Problem Set Due |
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
|
|
Vasoactive Drugs 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
Vasoactive Drugs 2
(Case - Cocaine)
(Case - Thyroid Disease) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
|
|
|
Nitric Oxide |
|
|
|
Quiz |
|
|
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
Antiinflammatory Drugs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
|
|
|
Antihistamines
(Case - Glaucoma)
(Case - Gout) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
Immunopharmacology
(Case - Renal Failure) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
Drug Development |
|
|
|
Drug Evaluation Due |
|
|
|
|
|
|
|
|
|
|
|
|
20 |
|
|
|
Drugs for Movement Dis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 |
|
|
|
Lipid Lowering Drugs
(Case - Placebo)
(Case - Lithium) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22 |
|
|
|
Anxiolytics/Antidepressants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23 |
|
|
|
Anticonvulsants
(Case - Placental Transfer)
(Case - Alcohol) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
|
|
|
Antimicrobials 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25 |
|
|
|
Antimicrobials 2
(Case - Drug Allergy)
(Case - Migraines) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26 |
|
|
|
Chemotherapy 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
Chemotherapy 2
(Case - Folate)
(Case - Oral Hypoglycemics) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28 |
|
|
|
Opioids 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
Opioids 2
(Case - Cancer, Analgesia)
(Case - Drug Abuse) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
|
|
|
|
|
|
|
Final Exam |
|
|
|
|
|
|